CSPC Pharmaceutical Group Limited (CSPCY)

CSPC Pharmaceutical Group Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 5, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	14,310	7,103	11,012	12,531	12,944	12,227
Market Cap Growth	120.06%	-35.50%	-12.12%	-3.19%	5.86%	-17.81%
Enterprise Value	13,247	5,847	9,550	10,844	11,313	11,298
Last Close Price	4.97	2.31	3.46	3.71	3.82	3.47
PE Ratio	25.08	11.98	13.30	14.19	14.67	15.47
PS Ratio	3.89	1.79	2.48	2.79	2.95	3.20
PB Ratio	2.92	1.53	2.23	2.73	3.07	3.46
P/TBV Ratio	3.36	1.76	2.53	3.08	3.24	3.68
P/FCF Ratio	-	20.58	30.56	15.99	25.49	14.83
P/OCF Ratio	-	11.43	18.68	11.33	17.73	11.84
EV/Sales Ratio	3.61	1.47	2.15	2.42	2.58	2.96
EV/EBITDA Ratio	17.10	6.62	8.53	9.83	10.31	11.98
EV/EBIT Ratio	22.74	7.95	9.65	11.07	11.50	13.48
EV/FCF Ratio	-	16.94	26.50	13.83	22.27	13.70
Debt / Equity Ratio	0.01	0.02	0.02	0.02	0.00	0.01
Debt / EBITDA Ratio	0.09	0.08	0.09	0.08	0.01	0.05
Debt / FCF Ratio	-	0.20	0.28	0.11	0.03	0.06
Asset Turnover	-	0.64	0.71	0.81	0.86	0.89
Inventory Turnover	-	2.78	3.26	3.45	3.10	2.85
Quick Ratio	-	1.95	2.32	2.39	2.47	2.22
Current Ratio	-	2.27	2.63	2.67	2.81	2.53
Return on Equity (ROE)	-	12.60%	18.22%	21.32%	22.79%	24.54%
Return on Assets (ROA)	-	7.40%	9.96%	11.04%	12.05%	12.13%
Return on Invested Capital (ROIC)	13.02%	17.69%	29.11%	33.40%	34.94%	31.93%
Return on Capital Employed (ROCE)	-	15.40%	19.40%	20.60%	22.70%	23.00%
Earnings Yield	3.99%	8.35%	7.52%	7.05%	6.82%	6.46%
FCF Yield	-	4.86%	3.27%	6.26%	3.92%	6.74%
Dividend Yield	1.96%	1.45%	1.05%	0.75%	0.63%	0.47%
Payout Ratio	-	74.72%	46.42%	34.42%	30.16%	29.61%
Buyback Yield / Dilution	2.93%	1.14%	0.38%	0.29%	0.01%	0.00%
Total Shareholder Return	4.89%	2.59%	1.43%	1.04%	0.64%	0.48%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.